Physician
Aduana, Ven
Aduana, Ven was paid $5.93M by Medicaid between Jan 2018 and Dec 2024, across 203 billing codes. Its largest line is U0002, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc — 10% of everything it billed.
33Billing provider infoADUANA, VEN
GENEVA, IL 60134
GENEVA, IL 60134
33aNPI1699757369assigned 11/17/2005
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$5.93M
24GClaims1,079,469
24DCodes billed203
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Rank by total paid#7 of 398
Median peer was paid$66K
This provider vs. median90×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 77,578 | $484K | |
| 2019 | 95,512 | $577K | |
| 2020 | 99,929 | $585K | |
| 2021 | 81,144 | $477K | |
| 2022 | 253,405 | $1.48M | |
| 2023 | 254,694 | $1.30M | |
| 2024incomplete | 217,207 | $1.02M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 10% | 13,104 | 11,533 | $602K |
| 80053 | Comprehensive metabolic panel | 9.5% | 108,702 | 68,982 | $563K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.3% | 165,541 | 90,888 | $490K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 5.9% | 2,351 | 2,019 | $350K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.4% | 24,543 | 22,175 | $203K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.1% | 7,835 | 5,724 | $184K |
| 83735 | 3.1% | 52,235 | 19,321 | $183K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.9% | 42,976 | 20,307 | $172K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.6% | 3,116 | 2,611 | $155K |
| 82948 | 2.4% | 56,902 | 14,835 | $142K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.1% | 3,501 | 3,254 | $123K |
| 87040 | 2.0% | 12,395 | 8,813 | $117K |
191 more codes
| 84484 | 2.0% | 26,892 | $117K | |
| 87641 | 1.8% | 4,732 | $106K | |
| 82805 | 1.7% | 3,875 | $103K | |
| 83880 | 1.6% | 7,956 | $93K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.5% | 2,061 | $89K |
| 83605 | 1.5% | 17,594 | $87K | |
| 83690 | 1.2% | 21,411 | $74K | |
| 80061 | Lipid panel | 1.1% | 19,139 | $67K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.1% | 2,891 | $67K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.1% | 2,870 | $66K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.1% | 12,315 | $63K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 17,729 | $57K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 2,229 | $56K |
| 86850 | <1% | 17,734 | $53K | |
| 85730 | <1% | 15,883 | $52K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 7,584 | $50K |
| 86901 | <1% | 21,289 | $49K | |
| 85027 | <1% | 15,655 | $45K | |
| 85610 | <1% | 22,204 | $44K | |
| 82947 | <1% | 14,613 | $44K | |
| 87186 | <1% | 6,419 | $39K | |
| 82607 | <1% | 6,395 | $39K | |
| 80047 | <1% | 8,988 | $39K | |
| 82803 | <1% | 4,531 | $38K | |
| 86900 | <1% | 21,300 | $37K | |
| 87486 | <1% | 1,628 | $37K | |
| 87581 | <1% | 1,624 | $36K | |
| 81003 | <1% | 29,283 | $33K | |
| 84100 | <1% | 20,233 | $33K | |
| 80076 | <1% | 9,220 | $31K | |
| 82728 | <1% | 7,322 | $31K | |
| 84439 | <1% | 6,803 | $30K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,555 | $28K |
| 83550 | <1% | 6,309 | $27K | |
| 80069 | <1% | 5,936 | $26K | |
| 84702 | <1% | 5,480 | $26K | |
| 86140 | <1% | 10,018 | $24K | |
| 84703 | <1% | 6,464 | $24K | |
| 83540 | <1% | 6,966 | $23K | |
| 88307 | <1% | 303 | $22K | |
| 85379 | <1% | 5,828 | $22K | |
| 80074 | <1% | 1,095 | $22K | |
| 82746 | <1% | 3,438 | $20K | |
| 82330 | <1% | 2,653 | $20K | |
| 80202 | <1% | 2,828 | $19K | |
| 88342 | <1% | 736 | $19K | |
| 83970 | <1% | 1,158 | $19K | |
| 81001 | <1% | 12,313 | $18K | |
| 83655 | <1% | 2,585 | $15K | |
| 83498 | <1% | 1,596 | $13K | |
| 87340 | <1% | 2,007 | $13K | |
| 82261 | <1% | 1,519 | $13K | |
| 86480 | <1% | 474 | $13K | |
| 82140 | <1% | 2,611 | $12K | |
| 80164 | <1% | 2,560 | $12K | |
| 82570 | <1% | 4,901 | $12K | |
| 87070 | <1% | 3,739 | $12K | |
| 86803 | <1% | 1,280 | $11K | |
| 83021 | <1% | 1,684 | $10K | |
| 87075 | <1% | 1,563 | $10K | |
| 82247 | <1% | 4,681 | $10K | |
| 82139 | <1% | 1,521 | $9K | |
| 82017 | <1% | 1,520 | $9K | |
| 86038 | <1% | 1,131 | $9K | |
| 87449 | <1% | 1,129 | $9K | |
| 86003 | <1% | 380 | $8K | |
| 84480 | <1% | 1,724 | $8K | |
| 87081 | <1% | 2,669 | $8K | |
| 85384 | <1% | 2,786 | $8K | |
| 82248 | <1% | 4,477 | $8K | |
| 82105 | <1% | 904 | $8K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 235 | $8K |
| 84436 | <1% | 2,206 | $8K | |
| 82550 | <1% | 3,037 | $8K | |
| 81025 | <1% | 4,325 | $8K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 205 | $7K |
| 87205 | <1% | 3,819 | $7K | |
| 87806 | <1% | 671 | $7K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 122 | $6K |
| 83615 | <1% | 2,289 | $6K | |
| 84550 | <1% | 3,135 | $6K | |
| 84145 | <1% | 528 | $6K | |
| 87210 | <1% | 2,171 | $5K | |
| 86706 | <1% | 704 | $5K | |
| 87631 | <1% | 89 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 103 | $5K |
| 87522 | Neg quan hep c or qual rna | <1% | 165 | $5K |
| 82951 | <1% | 731 | $5K | |
| 84481 | <1% | 842 | $4K | |
| 83516 | <1% | 766 | $4K | |
| 82378 | <1% | 627 | $4K | |
| 84156 | <1% | 3,747 | $4K | |
| 84030 | <1% | 1,707 | $4K | |
| 86762 | <1% | 899 | $4K | |
| 86880 | <1% | 1,270 | $4K | |
| 86787 | <1% | 487 | $4K | |
| 85018 | <1% | 4,010 | $4K | |
| 85014 | <1% | 3,847 | $4K | |
| 88313 | <1% | 179 | $3K | |
| 84146 | <1% | 493 | $3K | |
| 84132 | <1% | 2,582 | $3K | |
| 86920 | <1% | 719 | $3K | |
| 82784 | <1% | 480 | $3K | |
| 85652 | <1% | 2,154 | $3K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 316 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 124 | $3K |
| 82043 | <1% | 1,327 | $3K | |
| 85045 | <1% | 1,897 | $3K | |
| 88304 | <1% | 127 | $2K | |
| 82950 | <1% | 1,015 | $2K | |
| 86235 | <1% | 128 | $2K | |
| 84134 | <1% | 535 | $2K | |
| 86160 | <1% | 331 | $2K | |
| 86403 | <1% | 609 | $2K | |
| 87420 | <1% | 290 | $2K | |
| 84300 | <1% | 977 | $2K | |
| 82785 | <1% | 437 | $2K | |
| 82962 | <1% | 914 | $2K | |
| 86256 | <1% | 361 | $2K | |
| 82077 | <1% | 200 | $2K | |
| 82810 | <1% | 398 | $2K | |
| 80178 | <1% | 594 | $2K | |
| 83001 | <1% | 211 | $2K | |
| 87045 | <1% | 312 | $2K | |
| 83930 | <1% | 779 | $2K | |
| 82652 | <1% | 130 | $2K | |
| 82040 | <1% | 6,088 | $2K | |
| 82150 | <1% | 444 | $1K | |
| 82436 | <1% | 576 | $1K | |
| 84478 | <1% | 907 | $1K | |
| 89051 | <1% | 436 | $1K | |
| 82952 | <1% | 659 | $1K | |
| 84133 | <1% | 586 | $1K | |
| 82747 | <1% | 183 | $1K | |
| 86308 | <1% | 508 | $1K | |
| 82533 | <1% | 168 | $1K | |
| 86376 | <1% | 241 | $1K | |
| 85007 | <1% | 994 | $1K | |
| 84403 | <1% | 78 | $1K | |
| 84295 | <1% | 488 | $871.62 | |
| 86431 | <1% | 236 | $849.80 | |
| 86780 | <1% | 98 | $838.51 | |
| 83935 | <1% | 296 | $718.32 | |
| 87046 | <1% | 291 | $682.54 | |
| 86255 | <1% | 222 | $669.58 | |
| 86039 | <1% | 123 | $655.25 | |
| 86304 | <1% | 59 | $653.68 | |
| 86592 | <1% | 311 | $632.25 | |
| 85347 | <1% | 323 | $605.79 | |
| 87116 | <1% | 90 | $557.87 | |
| 82270 | <1% | 400 | $546.10 | |
| 82977 | <1% | 261 | $542.26 | |
| 86704 | <1% | 64 | $464.44 | |
| 85362 | <1% | 291 | $460.05 | |
| 80050 | General health panel | <1% | 534 | $439.33 |
| 84466 | <1% | 96 | $435.33 | |
| 87338 | <1% | 42 | $378.86 | |
| 83002 | <1% | 63 | $352.26 | |
| 87427 | <1% | 57 | $347.96 | |
| 83520 | <1% | 49 | $318.34 | |
| 87015 | <1% | 70 | $276.41 | |
| 82010 | <1% | 126 | $274.04 | |
| 85651 | <1% | 98 | $256.52 | |
| 86360 | <1% | 14 | $185.14 | |
| 84630 | <1% | 34 | $176.39 | |
| 86738 | <1% | 30 | $165.30 | |
| 84153 | <1% | 25 | $164.54 | |
| 82310 | <1% | 235 | $164.30 | |
| 87206 | <1% | 77 | $156.21 | |
| 82009 | <1% | 138 | $150.33 | |
| 86359 | <1% | 14 | $148.58 | |
| 87102 | <1% | 43 | $143.79 | |
| 86301 | <1% | 12 | $133.71 | |
| 84157 | <1% | 102 | $128.65 | |
| 82565 | <1% | 57 | $124.54 | |
| 82670 | <1% | 12 | $112.72 | |
| 86200 | <1% | 18 | $98.51 | |
| 83010 | <1% | 21 | $96.22 | |
| 87088 | <1% | 15 | $84.15 | |
| 86225 | <1% | 13 | $80.10 | |
| 86800 | <1% | 13 | $79.50 | |
| 82103 | <1% | 15 | $73.30 | |
| 82390 | <1% | 15 | $68.43 | |
| 86702 | <1% | 18 | $56.10 | |
| 86765 | <1% | 12 | $55.26 | |
| 87077 | <1% | 380 | $51.98 | |
| 84165 | <1% | 13 | $35.55 | |
| 86923 | <1% | 160 | $21.00 | |
| 80320 | <1% | 1,321 | $14.35 | |
| 80329 | 0% | 304 | $0.00 | |
| 80330 | 0% | 322 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.